12/06/2024
Recent clinical trial findings show that Menon’s nutraceutical product has both anti-diabetic and anti-hyperlipidemic properties. The nutraceutical showed improved efficacy in the control of elevated blood sugar, HbA1C and cholesterol levels in humans, with an average decrease in A1C of 33.5% over the 90 day period.
READ MORE 👉 https://menon.us/hba1c-reduced-by-over-30-in-type-2.../
